Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
CardiovascularINTRAVENOUSStandard

CLINOLIPID 20%

OLIVE OIL; SOYBEAN OIL

Standard Dose
16%(160GM/1000ML);4% (40GM/1000ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview CLINOLIPID 20% is listed in Drugs@FDA under application 204508 (NDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient OLIVE OIL; SOYBEAN OIL Form and strength EMULSION;INTRAVENOUS - 16%(160GM/1000ML);4% (40GM/1000ML) Sponsor BAXTER HLTHCARE CORP Submission history Latest submission status date: 2025-07-24 00:00:00.

Structured Monograph

Clinical summary

Approval overview CLINOLIPID 20% is listed in Drugs@FDA under application 204508 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient OLIVE OIL; SOYBEAN OIL Form and strength EMULSION;INTRAVENOUS - 16%(160GM/1000ML);4% (40GM/1000ML) Sponsor BAXTER HLTHCARE CORP Submission history Latest submission status date: 2025-07-24 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.
CLINOLIPID 20% (OLIVE OIL; SOYBEAN OIL) | Drug Monograph | MedicHelpline